ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single-center clinical utility study-PRECISE study.
<p><strong>INTRODUCTION:</strong> In this study (PRECISE), we assess the clinical utility of a germline DNA sequencing-based test (ToxNav) for mutations in DPYD and ENOSF1 genes to alter clinician-prescribed fluoropyrimidine doses and the use of a digital application (PROMinet) to...
Príomhchruthaitheoirí: | Lee, L, Starkey, T, Sivakumar, S, Fotheringham, S, Mozolowski, G, Shearwood, V, Palles, C, Camilleri, P, Church, D, Kerr, R, Kerr, D |
---|---|
Formáid: | Conference item |
Foilsithe / Cruthaithe: |
Wiley
2019
|
Míreanna comhchosúla
Míreanna comhchosúla
-
ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study
de réir: Lennard Y. W. Lee, et al.
Foilsithe / Cruthaithe: (2019-10-01) -
'Toxgnostics': An unmet need in cancer medicine
de réir: Church, D, et al.
Foilsithe / Cruthaithe: (2014) -
'Toxgnostics': an unmet need in cancer medicine.
de réir: Church, D, et al.
Foilsithe / Cruthaithe: (2014) -
DeepTox: Toxicity Prediction using Deep Learning
de réir: Andreas eMayr, et al.
Foilsithe / Cruthaithe: (2016-02-01) -
MitoTox: a comprehensive mitochondrial toxicity database
de réir: Yu-Te Lin, et al.
Foilsithe / Cruthaithe: (2021-07-01)